Embecta Corp. cotiza a 6.20 USD y tiene una capitalización bursátil de $351M. En los últimos 12 meses ha facturado $1.0B con un margen de flujo de caja libre del 16.9%. Cotiza a 2.1 veces su flujo de caja libre (P/FCF) y a un PER de 4.0. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing pati…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.56 | $0.27 | $0.71 |
| Estimado | $0.29 | $0.27 | $0.42 | $0.67 |
| Sorpresa | — | +107.4% | -35.7% | +6.0% |
| Métrica | EMBC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 62.6% | 57.0% | +5.6% |
| Operating Margin | 22.4% | -38.6% | +61.0% |
| Net Margin | 8.8% | -33.6% | +42.4% |
| FCF Margin | 16.9% | -13.9% | +30.7% |
| ROE | — | -40.4% | — |
| ROA | 8.8% | -32.0% | +40.8% |
| Current Ratio | 2.41 | 2.84 | -0.43 |
| Debt / Equity | -2.15 | 0.28 | -2.43 |